Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hybridoma Technology01:31

Hybridoma Technology

14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Towards light-coupled sample preparation for time-resolved cryoEM studies.

IUCrJ·2026
Same author

Author Correction: High-throughput discovery of fluoroprobes that recognize amyloid fibril polymorphs.

Nature chemistry·2026
Same author

Nanopipettes Enable Native Mass Spectrometry Studies of the Intrinsically Disordered Protein α-Synuclein in Biochemical Buffers.

Analytical chemistry·2026
Same author

The Cartesian Gaussian additive noise model for directed network inference in omics data.

BMC medical research methodology·2026
Same author

Preclinical characterization of AZD1163, a first-in-class anti-PAD2/4 bispecific antibody for the treatment of rheumatoid arthritis.

mAbs·2026
Same author

Integration of Membrane Proteins into the Outer Membrane of Diderm Bacteria by the BAM Complex.

Chemical reviews·2026
Same journal

Development of [<sup>111</sup>In]In-CHX-A″-DTPA-αCD68 for ImmunoSPECT to Image Murine Macrophages.

Molecular pharmaceutics·2026
Same journal

Mechanistic Insight into Self-Gelation Involved in Prescription Design for Optimization of Tablet Performance.

Molecular pharmaceutics·2026
Same journal

[<sup>68</sup>Ga]Ga-DOTA-DP-UBI 29-41: A Novel <sup>68</sup>Ga-Labeled Ubiquicidin 29-41 Derivative Containing d-Proline for Bacterial Infection PET Imaging.

Molecular pharmaceutics·2026
Same journal

Comparative Investigation of the Impact of Sodium Citrate Buffers on Lipid Nanoparticles of circRNA or Linear mRNA.

Molecular pharmaceutics·2026
Same journal

Preclinical Evaluation of <sup>177</sup>Lu-Labeled Anti-CLDN18.2 VHH-Fc for Radioimmunotherapy in Gastric Cancer.

Molecular pharmaceutics·2026
Same journal

The Impact of Plasticizer Polarity on the Permeability of Hydroxypropyl Methylcellulose Phthalate Films.

Molecular pharmaceutics·2026
查看所有相关文章

相关实验视频

Updated: Jun 5, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.6K

合理化mAb候选人选使用单一整体可开发性参数.

Leon F Willis1,2, Isabelle Trayton3, Janet C Saunders3

  • 1School of Molecular and Cellular Biology, Faculty of Biological Sciences, University of Leeds, Leeds LS2 9JT, U.K.

Molecular pharmaceutics
|December 16, 2024
PubMed
概括
此摘要是机器生成的。

选择最小可开发性试验 (DAs) 有助于药物开发. 本研究确定了五个关键的DA,用于预测mAb稳定性,降低成本和提高可持续性.

关键词:
抗体是一种抗体.开发能力评估 开发能力评估这是一种配方配方.动力稳定性的动力稳定性蛋白质聚合蛋白质的聚合物

更多相关视频

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.6K

相关实验视频

Last Updated: Jun 5, 2025

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System
10:50

Purification and Analytics of a Monoclonal Antibody from Chinese Hamster Ovary Cells Using an Automated Microbioreactor System

Published on: May 1, 2019

14.6K
An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.6K
Generation of Murine Monoclonal Antibodies by Hybridoma Technology
09:42

Generation of Murine Monoclonal Antibodies by Hybridoma Technology

Published on: January 2, 2017

41.6K

科学领域:

  • 生物制药的发展.
  • 蛋白质化学 蛋白质化学
  • 分析化学是一种分析化学.

背景情况:

  • 开发稳定的抗体配方需要强大的预测测定.
  • 目前选择可开发性试验 (DA) 的方法没有标准化,导致效率低下.
  • 评估候选药物的稳定性往往涉及许多测试,增加资源利用率.

研究的目的:

  • 建立一个框架来选择一组最小的可开发性试验.
  • 确定预测抗体 (mAb) 发育能力和存储稳定性的关键试验.
  • 优化资源配置,降低生物制药研究的开发成本.

主要方法:

  • 经过9个配方:mAbs的12个不同的可开发性测试.
  • 测量了mAbs.的加速和长期储存稳定性.
  • 采用直角统计方法,从试验数据中识别关键预测变量.

主要成果:

  • 确定了五个关键可开发性测试的缩小组.
  • 这五种测试可以在一天内在25°C下预测mAb降解率.
  • 选择的试验涵盖了一系列关键的物理化学特征,这些特征与稳定性有关.

结论:

  • 现在可以选择选择最小可开发性试验的合理框架.
  • 这种方法提高了药物开发的资源效率,可持续性和成本效益.
  • 使用最小DA套件的预测建模加速了稳定抗体候选人的识别.